Artisan Partners
APRE icon

Artisan Partners’s Aprea Therapeutics APRE Stock Holding History

Artisan Partners’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-25,889
Closed -$2.55M – 353
2020
Q4 		$2.55M Buy
25,889
+11,335
+78% +$5.39M ﹤0.01% 327
2020
Q3 		$7M Buy
14,554
+2,935
+25% +$1.64M 0.01% 307
2020
Q2 		$9.01M Buy
11,619
+155
+1% +$102K 0.01% 290
2020
Q1 		$7.97M Buy
11,464
+2,407
+27% +$1.77M 0.02% 275
2019
Q4 		$8.31M Buy
+9,057
New +$4.99M 0.01% 278

Other funds holding APRE

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Artisan Partners's APRE Position: Q1 2021 in Review

Artisan Partners sold out of Aprea Therapeutics (APRE) in Q1 2021, closing a stake of 25,889 shares — an estimated $2.55M sold.

Artisan Partners first reported a position in APRE in Q4 2019 and held it in 5 quarters. The position peaked at $9.01M in Q2 2020. 67 funds tracked by Wall St. Rank hold APRE as of Q1 2021.

  • Artisan Partners reported no remaining Aprea Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Artisan Partners sold 25,889 Aprea Therapeutics shares in Q1 2021, an estimated $2.55M.
  • Artisan Partners first reported a position in Aprea Therapeutics in Q4 2019 and held it in 5 quarters.
  • Artisan Partners's Aprea Therapeutics position peaked at $9.01M in Q2 2020.
  • 67 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q1 2021.

Based on Artisan Partners's 13F filing for Q1 2021, filed 11 May 2021.